In focus
Pierre Fabre and XtalPi Team Up on AI-Driven Drug Discovery
Laboratoires Pierre Fabre and XtalPi have signed an agreement to collaborate on discovering novel clinical candidates in oncology, potentially dermatology, and rare diseases. XtalPi will apply its AI and robotics platform to design small molecule therapeutics against undisclosed targets.
Read the story